US Stock MarketDetailed Quotes
SVA Sinovac Biotech
- 6.470
- 0.0000.00%
Trading Jul 5 09:30 ET
464.94MMarket Cap-4938P/E (TTM)
0.000High0.000Low0Volume0.000Open6.470Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)71.86MShares6.47052wk High0.05P/B208.92MFloat Cap6.47052wk Low--Dividend TTM32.29MShs Float12.500Historical High--Div YieldTTM0.00%Amplitude0.750Historical Low--Avg Price1Lot Size
Sinovac Biotech Stock Forum
Sign in to post a comment
$Sinovac Biotech (SVA.US)$
At the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what it perceived as China's growing influence in the Philippines, a nation hit especially hard by the deadly virus.
The clandestine operation has not been previously reported. It aimed to sow doubt about the safety and efficacy of vaccines and other life-saving aid that was being supplied by China, a Reu...
At the height of the COVID-19 pandemic, the U.S. military launched a secret campaign to counter what it perceived as China's growing influence in the Philippines, a nation hit especially hard by the deadly virus.
The clandestine operation has not been previously reported. It aimed to sow doubt about the safety and efficacy of vaccines and other life-saving aid that was being supplied by China, a Reu...
5
2
https://alphaedgeinvesting.com/2022/06/02/bllomberg-chinese-mrna-shot-beat-sinovac-as-booster-but-caused-more-fevers/
$Sinovac Biotech (SVA.US)$ $FOSUN PHARMA (02196.HK)$ $Shanghai Fosun Pharmaceutical (600196.SH)$ $CanSino Biologics Inc. (688185.SH)$ $CANSINOBIO (06185.HK)$ $Walvax Biotechnology (300142.SZ)$ $Chongqing Zhifei Biological Products (300122.SZ)$
$Sinovac Biotech (SVA.US)$ $FOSUN PHARMA (02196.HK)$ $Shanghai Fosun Pharmaceutical (600196.SH)$ $CanSino Biologics Inc. (688185.SH)$ $CANSINOBIO (06185.HK)$ $Walvax Biotechnology (300142.SZ)$ $Chongqing Zhifei Biological Products (300122.SZ)$
Key problem of $Novavax (NVAX.US)$ is lacking field data but several others have.
We now know so called 90%+ effecacy rates in phase 3 tests for many vaccines are really ..., you know. They were conducted under special controls, for instance, exclude risky people, etc. Furthermore, mask mandate, etc. policies expanded their "effecacy" - actually accumulative effecacy - should be vaccine + mask, etc.
For $BioNTech (BNTX.US)$/ $Pfizer (PFE.US)$, $Moderna (MRNA.US)$, $AstraZeneca (AZN.US)$, $SINOPHARM (01099.HK)$, $Sinovac Biotech (SVA.US)$ (trade suspended), at least, we have lots of field data on safety and real effecacy. Unless you are corrupted health officials own lots of NVAX shares, how dare you introduce NVAX to replace known ones?
Not to mention, NVAX still has not given a plausible explanation of their low effecacy in phase 2b test conducted in South Africa. Rather, NVAX left (should we say "flee"?) S. Africa and conducted phase 3 in US and Mexico.
Not just in US and Europe, even in China, you can see several late comers, despite claim better than in-use HK:1099 and SVA (trade supspended), they got little business.
I doubt Chinese government want SVA resume trade in Nasdaq because the company now worth a lot. As I read, in volume, SAV has sold most vaccines, BNTX/PFE cam second, and 099 third.
By the way, 1099 does show good safety, much better than BNTX/PFE: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473339/
We now know so called 90%+ effecacy rates in phase 3 tests for many vaccines are really ..., you know. They were conducted under special controls, for instance, exclude risky people, etc. Furthermore, mask mandate, etc. policies expanded their "effecacy" - actually accumulative effecacy - should be vaccine + mask, etc.
For $BioNTech (BNTX.US)$/ $Pfizer (PFE.US)$, $Moderna (MRNA.US)$, $AstraZeneca (AZN.US)$, $SINOPHARM (01099.HK)$, $Sinovac Biotech (SVA.US)$ (trade suspended), at least, we have lots of field data on safety and real effecacy. Unless you are corrupted health officials own lots of NVAX shares, how dare you introduce NVAX to replace known ones?
Not to mention, NVAX still has not given a plausible explanation of their low effecacy in phase 2b test conducted in South Africa. Rather, NVAX left (should we say "flee"?) S. Africa and conducted phase 3 in US and Mexico.
Not just in US and Europe, even in China, you can see several late comers, despite claim better than in-use HK:1099 and SVA (trade supspended), they got little business.
I doubt Chinese government want SVA resume trade in Nasdaq because the company now worth a lot. As I read, in volume, SAV has sold most vaccines, BNTX/PFE cam second, and 099 third.
By the way, 1099 does show good safety, much better than BNTX/PFE: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473339/
18
6
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
$BioNTech (BNTX.US)$ rose even more % wise. $Moderna (MRNA.US)$ also rose a lot. Faccui mentioned to redefine fully vaccinated.
Will 3rd, even 4th dose manditory?
Well, good news for BNTX and MRNA but only short term boost for $Novavax (NVAX.US)$ since market has matured. PFE/BNTX and MRNA have no production capacity issue now. There can produce as many as their addressable markets want.
Of course, there are no production issues for $SINOPHARM (01099.HK)$ and $Sinovac Biotech (SVA.US)$ (trade suspended). No, NVAX cannot capture noticeable markets from them.
Will 3rd, even 4th dose manditory?
Well, good news for BNTX and MRNA but only short term boost for $Novavax (NVAX.US)$ since market has matured. PFE/BNTX and MRNA have no production capacity issue now. There can produce as many as their addressable markets want.
Of course, there are no production issues for $SINOPHARM (01099.HK)$ and $Sinovac Biotech (SVA.US)$ (trade suspended). No, NVAX cannot capture noticeable markets from them.
33
4
Anti-vaccination groups are doing the same thing today. Everyone is susceptible to mind control when under great stress and disorientation, and these groups use social media to bombard their targets with messages that sow doubt, fear and confusion about the Covid-19 vaccine. As a result, a significant portion of the US population is refusing to get vaccinated and putting themselves at risk of being hospitalized or dying from Covid-19.
Helping people to overcome these fears is the only way to end this pandemic.
$Pfizer (PFE.US)$ $Sinovac Biotech (SVA.US)$ $AstraZeneca (AZN.US)$
Helping people to overcome these fears is the only way to end this pandemic.
$Pfizer (PFE.US)$ $Sinovac Biotech (SVA.US)$ $AstraZeneca (AZN.US)$
2
2
I believe vaccine stocks like $Moderna (MRNA.US)$ , $Pfizer (PFE.US)$ , $Sinovac Biotech (SVA.US)$ and companies that provide computing services like $Alphabet-A (GOOGL.US)$ , $Amazon (AMZN.US)$ , $Salesforce (CRM.US)$ , $Microsoft (MSFT.US)$, $Zoom Video Communications (ZM.US)$ as well as Electric Vehicles like $Tesla (TSLA.US)$ and $NIO Inc (NIO.US)$ are in prime position to shoot to all times high in t...
25
2
A Police Officer gathers $Pfizer (PFE.US)$ $Moderna (MRNA.US)$ $Sinovac Biotech (SVA.US)$ together for a meeting and asks them to each tell a Joke for 200 Moo-Moo points. In view of social distancing rules, they decided to do it via $Zoom Video Communications (ZM.US)$. Moderna and Sinovac each gave impressive jokes. When it was Pfizer’s turn, he could not finish his own joke before going into a huge laughing fit. The police concluded their INVESTigation that Pfizer was indeed the biggest LAUGHING stock. ...
3
Chinas healthcare stocks fall due to report that vaccine is less effective than previously announced. $Sinovac Biotech (SVA.US)$
13
3
Sinovac Weibo Account: The total global shipment of the inactivated CoronaVac exceeds 300 million doses.
$Sinovac Biotech (SVA.US)$
$Sinovac Biotech (SVA.US)$
1
$Sinovac Biotech (SVA.US)$ News Halt. watch
1
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
Falling angel : despicable
MonkeyGee : believable